E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Add to balance / Manage account  User:  Log out
Prospect News home > News index > List of issuers A > Headlines for Ankur Drugs and Pharma Ltd. > News item
Published on 9/30/2010 in the Prospect News Emerging Markets Daily.

India's Ankur Drugs and Pharma announces plans to issue debentures

By Devika Patel

Knoxville, Tenn., Sept. 30 - Ankur Drugs and Pharma Ltd. informed the Bombay Stock Exchange that it approved plans to issue up to Rs. 12.5 billion in debentures at an annual general meeting on Sept. 30.

Ankur is a pharmaceutical company based in Mumbai, India.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.